Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309042429
Category : Medical
Languages : en
Pages : 94
Book Description
Consensus Development at the NIH
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309042429
Category : Medical
Languages : en
Pages : 94
Book Description
Chronic Graft Versus Host Disease
Author: Georgia B. VogelsangPublisher: Cambridge University Press
ISBN: 1139478893
Category : Medical
Languages : en
Pages : 427
Book Description
Chronic graft versus host disease (GVHD) is the most common complication of allogenic bone marrow transplantation. Because of the protracted clinical course of chronic GVHD, transplant centers and hematology/oncology offices are inadequately equipped to manage these immuno-incompetent patients with a multi-system disorder. Practitioners need to be able to recognize and effectively manage chronic GVHD as a late effect of more than half of allogenic transplantations. The text is oriented for the clinician, with chapters covering staging, organ site and system-specific manifestations, treatment options, and supportive care. Drs Georgia B. Vogelsang and Steven Z. Pavletic have been pioneers in the recognition of the multi-organ complexity of this disease and have gathered the input of a variety of subspecialist physicians for this book. This book fills the gap in practical literature on chronic GVHD, providing a comprehensive, up-to-date, and clinically relevant resource for anyone who deals with cancer patients post-transplant.
Clinical Practice Guidelines We Can Trust
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 030921646X
Category : Medical
Languages : en
Pages : 217
Book Description
Advances in medical, biomedical and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of clinical practice guidelines and how they can be improved to enhance healthcare quality and patient outcomes. Clinical practice guidelines now are ubiquitous in our healthcare system. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy clinical practice guidelines emphasizing transparency; management of conflict of interest ; systematic review-guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality (AHRQ), as well as various Congressional staff and policymakers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use clinical practice guidelines, consumers, clinicians, and payers.
The NIH Consensus Development Program
Author: United States. Department of Health and Human Services. Office of Inspector GeneralPublisher:
ISBN:
Category : Medicine
Languages : en
Pages : 85
Book Description
NIH Consensus Development Conference Summary
Author: National Institutes of Health (U.S.)Publisher:
ISBN:
Category : Medical innovations
Languages : en
Pages :
Book Description
NIH Consensus Development Conference Summary
Author: Improving Consensus Development for Health Technology Assessment
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309042399
Category : Medical
Languages : en
Pages : 176
Book Description
Considers medical technology consensus development programs in Canada, Denmark, Finland, Netherlands, Norway, Sweden, England and the United States.
NIH Consensus Statement
Author: Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 3
Author: National Research CouncilPublisher: National Academies Press
ISBN: 0309225477
Category : Science
Languages : en
Pages : 22
Book Description
In 2003, the Boston University Medical Center (BUMC) was awarded a $128 million grant from the National Institutes of Health (NIH) to build one of two national maximum-containment laboratory facilities for pathogen research. The National Emerging Infectious Diseases Laboratories (NEIDL) are meant to support the National Institute of Allergy and Infectious Diseases' biodefense research agenda, conducting research to develop new approaches to treating, preventing, and diagnosing a variety of bacterial and viral diseases. The facility includes a biosafety level 4 (BSL-4) containment laboratory housed in a 192,000 square foot building. Although the NEIDL BSL-4 laboratory accounts for only 13 percent of the building's total space, it has been the source of virtually all of the community concern surrounding this project. The location of the facility on Albany Street in Boston's South End, which is an environmental justice community, has been controversial, and there have been numerous public meetings over the plans for the facility as well as three legal actions challenging the project. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 3, the fifth in a series of reports about the proposed facility, provides further technical input on the scope and design of any additional studies that may be needed to assess the risks associated with the siting and operation of the NEIDL. This report presents comments and questions on a "90 percent", or penultimate, draft of the revised risk assessment. According to the report, the "90 percent" draft of the risk assessment is a substantial improvement over past documents reviewed. Additionally, the report makes recommendations to improve the version that is ultimately prepared for public comment.
National Institutes of Health Consensus Development Conference Summaries
Author: National Institutes of Health (U.S.)Publisher:
ISBN:
Category : Medical innovations
Languages : en
Pages : 218
Book Description